Related Experiment Video
Updated: Apr 20, 2026
04:34
Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
1.9K
Bone-anchored hearing device placement with translabyrinthine tumor removal
Theodore R McRackan1, John C Goddard1, Eric P Wilkinson1
1House Clinic, Los Angeles, California, USA.
Summary
Surgically implanted bone-anchored hearing devices (BAHD) can be safely placed during translabyrinthine tumor removal. This procedure showed low complication rates and high long-term usage, similar to standard BAHD placement.
Area of Science:
- Neurosurgery
- Otolaryngology
- Audiology
Background:
- Translabyrinthine tumor resection causes single-sided deafness, necessitating hearing rehabilitation.
- Bone-anchored hearing devices (BAHD) offer a surgical solution for hearing loss.
Purpose of the Study:
- To evaluate complication and device usage rates of concurrent BAHD placement during translabyrinthine tumor removal.
- To compare these rates with published data for standard BAHD implantation.
Main Methods:
- A case series with chart review was conducted.
- 154 patients underwent concurrent BAHD placement and translabyrinthine tumor resection.
- Postoperative complications and BAHD usage were tracked.
Main Results:
- 121 out of 154 patients (78.6%) experienced no device-related complications.
- The most common complications were skin overgrowth (8.4%), acute infection (5.2%), and chronic infection (3.2%).
- Long-term device usage was high, with 151 patients (95.0%) using their BAHD at mean follow-up of 39.8 months.
Conclusions:
- Concurrent BAHD placement during translabyrinthine surgery has complication rates comparable to standard BAHD procedures.
- The high long-term usage supports BAHD insertion as a safe and effective option during these surgeries.
Keywords:
acoustic neuromabone-anchored hearing aidbone-anchored hearing devicesingle-sided deafnesstranslabyrinthinevestibular schwannoma
